Skip to content
Velorum Therapeutics logo

Velorum Therapeutics

Velorum Therapeutics is a YC Winter 2024 (W24) company. Based in San Francisco, CA, USA. Team of 5.

  • Biotech
  • Healthcare
  • Therapeutics
  • Drug discovery
  • Oncology

About Velorum Therapeutics

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Velorum Therapeutics develops drugs that target heme biology, an area of disease mechanism that has seen little pharmaceutical attention. Heme dysregulation drives conditions including porphyrias, certain cancers, and organ injury from tissue damage, and Velorum builds therapies aimed at each of those disease contexts. The work replaces a gap in the existing drug landscape rather than a prior generation of treatments.

From the Y Combinator listing

How Velorum Therapeutics describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Breakthrough medicines unlocking the biology of heme

Velorum Therapeutics is developing breakthrough medicines by unlocking the biology of heme.

Facts

Industry
Healthcare / Healthcare -> Therapeutics
Location
San Francisco, CA, USA
Team size
5
Status
Active
Stage
Early

Founders (2)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works